Logo image of NCNO

NCINO INC (NCNO) Stock Fundamental Analysis

NASDAQ:NCNO - US63947X1019 - Common Stock

29.08 USD
+1.28 (+4.6%)
Last: 8/22/2025, 8:26:55 PM
28.98 USD
-0.1 (-0.34%)
Pre-Market: 8/25/2025, 4:24:58 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NCNO. NCNO was compared to 282 industry peers in the Software industry. NCNO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, NCNO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NCNO was profitable.
In the past year NCNO had a positive cash flow from operations.
NCNO had negative earnings in each of the past 5 years.
In multiple years NCNO reported negative operating cash flow during the last 5 years.
NCNO Yearly Net Income VS EBIT VS OCF VS FCFNCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

NCNO has a Return On Assets (-1.78%) which is comparable to the rest of the industry.
The Return On Equity of NCNO (-2.74%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
NCNO Yearly ROA, ROE, ROICNCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 60.05%, NCNO is doing worse than 62.06% of the companies in the same industry.
NCNO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NCNO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
NCNO Yearly Profit, Operating, Gross MarginsNCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
NCNO has more shares outstanding than it did 1 year ago.
NCNO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NCNO is higher compared to a year ago.
NCNO Yearly Shares OutstandingNCNO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NCNO Yearly Total Debt VS Total AssetsNCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.49 indicates that NCNO is not in any danger for bankruptcy at the moment.
The Altman-Z score of NCNO (3.49) is better than 61.35% of its industry peers.
The Debt to FCF ratio of NCNO is 5.06, which is a neutral value as it means it would take NCNO, 5.06 years of fcf income to pay off all of its debts.
NCNO has a Debt to FCF ratio of 5.06. This is comparable to the rest of the industry: NCNO outperforms 59.22% of its industry peers.
NCNO has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.24, NCNO is in line with its industry, outperforming 43.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Altman-Z 3.49
ROIC/WACCN/A
WACC11.23%
NCNO Yearly LT Debt VS Equity VS FCFNCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

NCNO has a Current Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, NCNO is not doing good in the industry: 70.57% of the companies in the same industry are doing better.
NCNO has a Quick Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, NCNO is not doing good in the industry: 69.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NCNO Yearly Current Assets VS Current LiabilitesNCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

5

3. Growth

3.1 Past

NCNO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
NCNO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.40%.
NCNO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.37% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%

3.2 Future

Based on estimates for the next years, NCNO will show a very strong growth in Earnings Per Share. The EPS will grow by 22.85% on average per year.
Based on estimates for the next years, NCNO will show a quite strong growth in Revenue. The Revenue will grow by 9.08% on average per year.
EPS Next Y10.11%
EPS Next 2Y19.92%
EPS Next 3Y22.85%
EPS Next 5YN/A
Revenue Next Year7.65%
Revenue Next 2Y8.22%
Revenue Next 3Y9.08%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NCNO Yearly Revenue VS EstimatesNCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
NCNO Yearly EPS VS EstimatesNCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

NCNO is valuated quite expensively with a Price/Earnings ratio of 46.16.
Compared to the rest of the industry, the Price/Earnings ratio of NCNO is on the same level as its industry peers.
NCNO's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.24.
Based on the Price/Forward Earnings ratio of 30.64, the valuation of NCNO can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NCNO indicates a somewhat cheap valuation: NCNO is cheaper than 62.77% of the companies listed in the same industry.
NCNO is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.16
Fwd PE 30.64
NCNO Price Earnings VS Forward Price EarningsNCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

NCNO's Enterprise Value to EBITDA ratio is in line with the industry average.
NCNO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 65.36
EV/EBITDA 152.38
NCNO Per share dataNCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NCNO does not grow enough to justify the current Price/Earnings ratio.
NCNO's earnings are expected to grow with 22.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.57
PEG (5Y)N/A
EPS Next 2Y19.92%
EPS Next 3Y22.85%

0

5. Dividend

5.1 Amount

No dividends for NCNO!.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (8/22/2025, 8:26:55 PM)

Premarket: 28.98 -0.1 (-0.34%)

29.08

+1.28 (+4.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners115.27%
Inst Owner Change0.28%
Ins Owners1.44%
Ins Owner Change20.56%
Market Cap3.37B
Analysts73.04
Price Target32.56 (11.97%)
Short Float %11.36%
Short Ratio9.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.26%
Min EPS beat(2)-36.6%
Max EPS beat(2)-1.92%
EPS beat(4)2
Avg EPS beat(4)-0.66%
Min EPS beat(4)-36.6%
Max EPS beat(4)28.46%
EPS beat(8)6
Avg EPS beat(8)20.37%
EPS beat(12)9
Avg EPS beat(12)17.38%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.6%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)0.4%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)0.4%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.52%
Revenue beat(16)7
Avg Revenue beat(16)0.4%
PT rev (1m)1.97%
PT rev (3m)23.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.82%
EPS NY rev (1m)0.22%
EPS NY rev (3m)1.73%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 46.16
Fwd PE 30.64
P/S 6.06
P/FCF 65.36
P/OCF 61.21
P/B 3.14
P/tB N/A
EV/EBITDA 152.38
EPS(TTM)0.63
EY2.17%
EPS(NY)0.95
Fwd EY3.26%
FCF(TTM)0.44
FCFY1.53%
OCF(TTM)0.48
OCFY1.63%
SpS4.8
BVpS9.25
TBVpS-1.46
PEG (NY)4.57
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.05%
FCFM 9.27%
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Debt/EBITDA 11.29
Cap/Depr 9.01%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion 239.84%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.49
F-Score5
WACC11.23%
ROIC/WACCN/A
Cap/Depr(3y)23.11%
Cap/Depr(5y)36.46%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y10.11%
EPS Next 2Y19.92%
EPS Next 3Y22.85%
EPS Next 5YN/A
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%
Revenue Next Year7.65%
Revenue Next 2Y8.22%
Revenue Next 3Y9.08%
Revenue Next 5YN/A
EBIT growth 1Y48.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.42%
EBIT Next 3Y25.04%
EBIT Next 5YN/A
FCF growth 1Y3539%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y275.44%
OCF growth 3YN/A
OCF growth 5YN/A